Gabapentin as a Pre-emptive Analgesic in Oral and Maxillofacial Surgical Procedures

• Status: Unknown status
• Trial end date: 2021-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the effectiveness of pre-operative administration of gabapentin 900 mg in management of acute post-operative pain in patients undergoing oral and maxillofacial surgical procedures.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Massachusetts General Hospital
• Treatments: Analgesics; Gabapentin; gamma-Aminobutyric Acid

Criteria

Inclusion Criteria:

1. Male or female participants, of any race, between ages of 18 - 65 years.

2. Participants undergoing unilateral or bilateral Lefort osteotomy, unilateral or bilateral mandibular inverted-L or sagittal split osteotomy with or without genioplasty, temporomandibular joint arthroplasty with or without total joint replacement prosthesis.

Exclusion Criteria:

1. Participants who are pregnant.

2. Participants allergic to gabapentin.

3. Participants with a history of alcohol, or drug abuse.

4. Participants who are unwilling to participate, or are non-compliant to the guidelines of the investigation.